Moreover, miR-19b-3p can increase the expression of Bcl-2 by targeting tumor necrosis factor alpha-induced protein 3 (TNFAIP3, also known as A20), while the expression of apoptosis-promoting factor Bax is decreased in NPC tissues and cells. This evidence concerns the gene BAX and nasopharyngeal carcinoma.